Sofiabad M, Heidari N, Ghasemi E, Esmaeili M H, Haghdoost-Yazdi H, Erami E et al . Assesment of orexin receptor 1 in stress attenuated nociceptive behaviours in formalin test. Physiol Pharmacol 2011; 15 (3) :395-402
URL:
http://ppj.phypha.ir/article-1-732-en.html
Abstract: (15186 Views)
Introduction: It is known that acute and chronic stress induce hormonal and neuronal changes which affecting both
pain threshold and nociceptive behaviours. Orexin plays an important role in modulation of pain and stress. Considering
pain modulation during stress and the role of orexin in pain and stress, orexin might be involved in pain modulation
during stress.We evaluated the involvement of orexin receptor-1in acute immobilization stress on the tonic pain model.
Methods: Adult male, Wistar rats (200–300 g), placed in a stereotaxic apparatus and canulla were inserted into their
left cerebral ventricle. After 1 week of recovery, animals were initially submitted to one session of acute restraint stress
(30 min) and immediately submitted to formalin injection in the hind paw to evaluate nociceptive behaviours. Orexin
receptor 1 antagonist (SB 334867) was injected intracerebroventricularly, 5 minute before formalin injection, while the
solvent was injected in the control group.
Results: two percent formalin produced typical biphasic pain responses in rats that was observed for more than 1
hour. Acute exposure to restraint stress reduced the nociceptive behaviour by chemical stimulation in phase 1,
interphase and phase 2. The short-term stress induced analgesia was reflected in a decrease in the nociceptive behaviour
during phase 1, whereas the long-term stress induced analgesia was reflected in a decrease in the nociceptive behaviours
during phase 2. Pretreatment with orexin receptor 1 antagonist (SB 334867) attenuated the antinociceptive behavioral
effect of restraint stress.
Conclusion: Our results indicate that orexin receptor 1 antagonist attenuated antinociceptive effect of restraint stress
assessed by formalin. These findings show that orexin receptor 1 might mediate an opioid-independent stress-induced
analgesia.